UNCOS

Nanodroplets could speed up the search for new medicine

August 21, 2025, 12:31 PM

  • KIT researchers developed a nanodroplet platform for drug discovery.
  • The platform uses miniaturized nanodroplets to test therapeutic agents.
  • It combines synthesis, testing, and analysis on a single chip.
  • The approach enables faster and cheaper drug discovery.
  • The platform can accelerate drug discovery for cancer therapy.

Researchers at Karlsruhe Institute of Technology (KIT) have created a novel nanodroplet platform to accelerate early-stage drug discovery, synthesizing, characterizing, and testing thousands of therapeutic agents on a single chip. This miniaturized approach, using nanodroplets as small as a grain of sand, significantly reduces the time and resources required compared to traditional methods. The platform allows for the direct-to-biology testing of synthesized molecules, enabling academic and smaller institutions to contribute to drug development. Utilizing this technology, the researchers successfully produced and tested 325 potential MEK inhibitors, identifying 46 with comparable efficacy to a known drug, thus paving the way for faster and more efficient drug discovery.

Read original article

Entities Mentioned

Lisa LockRobert EganPavel LevkinLiana BauerCarsten HopfMaximilian Seifermann

Topics Covered

Bio & Medicine

Comments (0)

No comments yet.